Ossifying Fibromyxoid Tumor of the Genitourinary Tract

Ossifying fibromyxoid tumors (OFMTs) are rare mesenchymal neoplasms which typically present in the superficial subcutaneous tissues and have not been reported to arise in visceral organs. We now report 4 molecularly confirmed cases of OFMT involving the genitourinary tract. All patients were males, ranging in age from 20 to 66 years (mean: 43 y). One case each arose in the kidney, ureter, perirenal soft tissue, and penis. All neoplasms demonstrated bland epithelioid to spindled cells set in a variably fibrous to fibromyxoid stroma, and only 1 had a peripheral shell of lamellar bone. All cases appeared well-circumscribed on gross/radiologic examination, though the primary renal neoplasm permeated between native renal tubules. By immunohistochemistry, S100 protein was negative in all 4 cases, while desmin was positive in 2 cases. In 2 cases, the Illumina TruSight RNA Fusion Panel demonstrated a PHF1::TFE3 and EP400::PHF1 fusion, respectively. In the remaining 2 cases, PHF1 gene rearrangement was confirmed by fluorescence in situ hybridization analysis. Due to unusual clinical presentation, lack of S100 positivity, and only occasional bone formation, the correct diagnosis was challenging in the absence of molecular testing. In summary, OFMT may rarely present primarily in the genitourinary tract. Given their nonspecific morphology and immunophenotype, molecular analysis is crucial to establish the correct diagnosis.

[1]  C. Antonescu,et al.  GLI1 Gene Alterations in Neoplasms of the Genitourinary and Gynecologic Tract , 2021, The American journal of surgical pathology.

[2]  N. Katabi,et al.  Myoepithelial Carcinoma. , 2021, Surgical pathology clinics.

[3]  S. Wong,et al.  Superficial malignant ossifying fibromyxoid tumors harboring the rare and recently described ZC3H7B‐BCOR and PHF1‐TFE3 fusions , 2020, Journal of cutaneous pathology.

[4]  C. Antonescu,et al.  A morphologic and molecular reappraisal of genetically confirmed myoepithelial tumors of soft tissue, bone and viscera. , 2020, Genes, chromosomes & cancer.

[5]  F. Mertens,et al.  PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells , 2020, Modern Pathology.

[6]  C. Antonescu,et al.  Novel recurrent PHF1‐TFE3 fusions in ossifying fibromyxoid tumors , 2019, Genes, chromosomes & cancer.

[7]  S. Yip,et al.  Novel EPC1 gene fusions in endometrial stromal sarcoma , 2018, Genes, chromosomes & cancer.

[8]  Cheng-Han Lee,et al.  Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations. , 2017, Pathology.

[9]  C. Antonescu,et al.  Primary Renal Sarcomas With BCOR-CCNB3 Gene Fusion: A Report of 2 Cases Showing Histologic Overlap With Clear Cell Sarcoma of Kidney, Suggesting Further Link Between BCOR-related Sarcomas of the Kidney and Soft Tissues , 2017, The American journal of surgical pathology.

[10]  C. Antonescu,et al.  Expanding the molecular signature of ossifying fibromyxoid tumors with two novel gene fusions: CREBBP‐BCORL1 and KDM2A‐WWTR1 , 2017, Genes, chromosomes & cancer.

[11]  C. Fisher,et al.  Ossifying fibromyxoid tumor: morphology, genetics, and differential diagnosis. , 2016, Annals of diagnostic pathology.

[12]  J. Goldblum,et al.  Ossifying fibromyxoid tumor: a clinicopathologic analysis of 26 subcutaneous tumors with emphasis on differential diagnosis and prognostic factors , 2015, Journal of cutaneous pathology.

[13]  Narasimhan P. Agaram,et al.  Dichotomy of Genetic Abnormalities in PEComas With Therapeutic Implications , 2015, The American journal of surgical pathology.

[14]  C. Antonescu,et al.  Primary Renal Sclerosing Epithelioid Fibrosarcoma: Report of 2 Cases With EWSR1-CREB3L1 Gene Fusion , 2015, The American journal of surgical pathology.

[15]  Narasimhan P. Agaram,et al.  A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low‐grade fibromyxoid sarcoma: A pathologic and molecular study of 18 cases , 2015, Genes, chromosomes & cancer.

[16]  C. Fisher,et al.  Recurrent EWSR1-CREB3L1 Gene Fusions in Sclerosing Epithelioid Fibrosarcoma , 2014, The American journal of surgical pathology.

[17]  P. Argani,et al.  t(6;11) Renal Cell Carcinoma (RCC): Expanded Immunohistochemical Profile Emphasizing Novel RCC Markers and Report of 10 New Genetically Confirmed Cases , 2014, The American journal of surgical pathology.

[18]  Narasimhan P. Agaram,et al.  Novel ZC3H7B‐BCOR, MEAF6‐PHF1, and EPC1‐PHF1 fusions in ossifying fibromyxoid tumors—molecular characterization shows genetic overlap with endometrial stromal sarcoma , 2014, Genes, chromosomes & cancer.

[19]  A. Venyo Nested Variant of Urothelial Carcinoma , 2014, Advances in urology.

[20]  J. Goldblum,et al.  PHF1 Rearrangements in Ossifying Fibromyxoid Tumors of Soft Parts: A Fluorescence In Situ Hybridization Study of 41 Cases With Emphasis on the Malignant Variant , 2013, The American journal of surgical pathology.

[21]  A. Folpe,et al.  JAZF1 Rearrangement in a Mesenchymal Tumor of Nonendometrial Stromal Origin: Report of an Unusual Ossifying Sarcoma of the Heart Demonstrating JAZF1/PHF1 Fusion , 2013, The American journal of surgical pathology.

[22]  D. Huntsman,et al.  Endometrial Stromal Sarcomas With Sex Cord Differentiation Are Associated With PHF1 Rearrangement , 2013, The American journal of surgical pathology.

[23]  P. D. Dal Cin,et al.  MUC4 Is a Sensitive and Extremely Useful Marker for Sclerosing Epithelioid Fibrosarcoma: Association With FUS Gene Rearrangement , 2012, The American journal of surgical pathology.

[24]  O. Larsson,et al.  Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. , 2012, The American journal of pathology.

[25]  P. Argani,et al.  Perivascular epithelioid cell tumors (PEComas) harboring TFE3 gene rearrangements lack the TSC2 alterations characteristic of conventional PEComas: further evidence for a biological distinction. , 2012, The American journal of surgical pathology.

[26]  C. Antonescu,et al.  EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene , 2010, Genes, chromosomes & cancer.

[27]  M. Ladanyi,et al.  A Distinctive Subset of PEComas Harbors TFE3 Gene Fusions , 2010, The American journal of surgical pathology.

[28]  F. Montorsi,et al.  Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? , 2008, European urology.

[29]  M. Miettinen,et al.  Ossifying Fibromyxoid Tumor of Soft Parts—A Clinicopathologic and Immunohistochemical Study of 104 Cases With Long-term Follow-up and a Critical Review of the Literature , 2008, The American journal of surgical pathology.

[30]  F. Collin,et al.  Translocation-positive Low-grade Fibromyxoid Sarcoma: Clinicopathologic and Molecular Analysis of a Series Expanding the Morphologic Spectrum and Suggesting Potential Relationship to Sclerosing Epithelioid Fibrosarcoma: A Study From the French Sarcoma Group , 2007, The American journal of surgical pathology.

[31]  J. Fletcher,et al.  The chimeric FUS/CREB3l2 gene is specific for low‐grade fibromyxoid sarcoma , 2004, Genes, chromosomes & cancer.

[32]  A. Folpe,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathologic Study of 70 Cases With Emphasis on Atypical and Malignant Variants , 2003, The American journal of surgical pathology.

[33]  M. Ladanyi,et al.  Skeletal and extraskeletal myxoid chondrosarcoma , 1998, Cancer.

[34]  T. Motoyama,et al.  Ossifying fibromyxoid tumor of the retroperitoneum , 1996, Pathology international.

[35]  H. Ito,et al.  Ossifying fibromyxoid tumor of soft parts: a case report. , 1993, Japanese journal of clinical oncology.

[36]  S. Weiss,et al.  Ossifying Fibromyxoid Tumor of Soft Parts: A Clinicopathological Analysis of 59 Cases , 1989, The American journal of surgical pathology.

[37]  C. Antonescu,et al.  BCOR Overexpression in Renal Malignant Solitary Fibrous Tumors: A Close Mimic of Clear Cell Sarcoma of Kidney , 2019, The American journal of surgical pathology.

[38]  Narasimhan P. Agaram,et al.  A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions , 2018, The American journal of surgical pathology.